{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:49:27Z","timestamp":1778784567953,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10549-013-2564-4","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T04:13:39Z","timestamp":1369023219000},"page":"571-579","source":"Crossref","is-referenced-by-count":25,"title":["Simplifying clinical use of the genetic risk prediction model BRCAPRO"],"prefix":"10.1007","volume":"139","author":[{"given":"Swati","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philamer","family":"Atienza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Chipman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica M. Gutierrez","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher I.","family":"Amos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Arun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Parmigiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"2564_CR1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, et\u00a0al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"2564_CR2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646","journal-title":"Science"},{"key":"2564_CR3","doi-asserted-by":"crossref","unstructured":"Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ; Consensus Conference Committee The International Consensus Conference Committee. (2008) Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Cancer 113:2627\u20132637","DOI":"10.1002\/cncr.23903"},{"key":"2564_CR4","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1245\/s10434-012-2257-y","volume":"19","author":"B Drohan","year":"2012","unstructured":"Drohan B, Roche CA, Cusack JC, Hughes KS (2012) Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol 19:1732\u20131737","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 1","key":"2564_CR5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1524-4741.2009.00796.x","volume":"15","author":"B Drohan","year":"2009","unstructured":"Drohan B, Ozanne EM, Hughes KS (2009) Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer. Breast J 15(Suppl 1):46\u201355","journal-title":"Breast J"},{"key":"2564_CR6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145\u2013158","journal-title":"Am J Hum Genet"},{"key":"2564_CR7","doi-asserted-by":"crossref","first-page":"Article21","DOI":"10.2202\/1544-6115.1063","volume":"3","author":"S Chen","year":"2004","unstructured":"Chen S, Wang W, Broman KW, et\u00a0al (2004) BayesMendel: an R environment for Mendelian risk prediction. Stat Appl Genet Mol Biol 3:Article21","journal-title":"Stat Appl Genet Mol Biol"},{"key":"2564_CR8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/bcr1866","volume":"10","author":"YC Tai","year":"2008","unstructured":"Tai YC, Chen S, Parmigiani G, et\u00a0al (2008) Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction. Breast Cancer Res 10:401","journal-title":"Breast Cancer Res"},{"key":"2564_CR9","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1002\/sim.3302","volume":"27","author":"HA Katki","year":"2008","unstructured":"Katki HA, Blackford A, Chen S, et\u00a0al (2008) Multiple diseases in carrier probability estimation: accounting for surviving all cancers other than breast and ovary in BRCAPRO. Stat Med 27:4532\u20134548","journal-title":"Stat Med"},{"key":"2564_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2350-8-13","volume":"8","author":"HA Katki","year":"2007","unstructured":"Katki HA (2007) Incorporating medical interventions into Mendelian mutation prediction models. BMC Med Genet 8:13","journal-title":"BMC Med Genet"},{"key":"2564_CR11","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1200\/JCO.2008.20.6896","volume":"27","author":"S Chen","year":"2009","unstructured":"Chen S, Blackford AL, Parmigiani G (2009) Tailoring BRCAPRO to Asian-Americans. J Clin Oncol 27:642\u2013643","journal-title":"J Clin Oncol"},{"key":"2564_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-012-1958-z","volume":"133","author":"S Biswas","year":"2012","unstructured":"Biswas S, Tankhiwale N, Blackford A, et\u00a0al (2012) Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO. Breast Cancer Res Treat 133:347\u2013355","journal-title":"Breast Cancer Res Treat"},{"key":"2564_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1524-4741.2009.00690.x","volume":"15","author":"EM Ozanne","year":"2009","unstructured":"Ozanne EM, Loberg A, Hughes S, et\u00a0al (2009) Identification and management of women at high risk for hereditary breast\/ovarian cancer syndrome. Breast J 15:155\u2013162","journal-title":"Breast J"},{"key":"2564_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1399-0004.2000.580408.x","volume":"58","author":"CA Gilpin","year":"2000","unstructured":"Gilpin CA, Carson N, Hunter AG (2000) A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center. Clin Genet 58:299\u2013308","journal-title":"Clin Genet"},{"key":"2564_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-147-7-200710020-00002","volume":"147","author":"G Parmigiani","year":"2007","unstructured":"Parmigiani G, Chen S, Iversen ES, et\u00a0al (2007) Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147:441\u2013450","journal-title":"Ann Intern Med"},{"key":"2564_CR16","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.296.12.1479","volume":"296","author":"S Chen","year":"2006","unstructured":"Chen S, Wang W, Lee S, et\u00a0al (2006) Prediction of germline mutations and cancer risk in the Lynch syndrome. J Am Med Assoc 296:1479\u20131487","journal-title":"J Am Med Assoc"},{"key":"2564_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB, D\u2019Agostino RB, Vasan RS. (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157\u2013172","journal-title":"Stat Med"},{"key":"2564_CR18","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","volume-title":"An Introduction to the Bootstrap","author":"B Efron","year":"1994","unstructured":"Efron B, Tibshirani R (1994) An introduction to the bootstrap. Chapman and Hall\/CRC, Boca Raton"},{"key":"2564_CR19","unstructured":"Parmigiani G (2002) Modeling in medical decision making: a Bayesian approach. Wiley, Chichester"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-013-2564-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2564-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T22:37:20Z","timestamp":1595803040000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-013-2564-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2564"],"URL":"https:\/\/doi.org\/10.1007\/s10549-013-2564-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]}}}